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Editorial on the Research Topic
Recent Advances in Psychiatry from Psycho-Neuro-Immunology Research: Auto
immunencephalitis, Autoimmune-Encephalopathy, Mild Encephalitis
The precise etiopathophysiology of most severe mental disorders, particularly schizophrenia
spectrum and affective spectrum disorders, remains unclear but is thought to be a product
of the intricate interplay among a number of risk factors. These include interactions between
genetic, developmental and environmental factors, such as infections. Indeed, the evidence from
many epidemiological studies carried out in different countries, especially those from Denmark,
strongly associates both early and the frequency and severity of life-time infections with an
increased risk of psychosis in later life, possibly through diverse immunological mechanisms. More
recently, the continued discovery of antibodies against various neuronal cell surface proteins, such
as anti-N-methyl-d-aspartate receptor (NMDAR) and gamma-aminobutyric acid beta receptor
(GABAßR), directly links central nervous system (CNS) autoimmunity with dysregulation of
glutamatergic and GABAergic neurotransmitter pathways to the neurobiology of acute psychosis
in individuals with autoimmune encephalitis (AE). These findings, along with the rapidly emerging
evidence of many other immunological abnormalities in most severe mental disorders, have
made it clear that the nexus of psychiatry, neurology, and neuroimmunology represent a fruitful
coalescence in understanding the pathogenesis of psychiatric disease. The interactive presentations
on the link between immune dysregulation and various mental disorders during the 13 and
14th Psychoimmunology expert meetings in 2016 and 2018 at Ulm University in Germany
(www.psychoimmunology-experts.de) generated widespread interest and discussion among the
participants, which led to identifying and planning this research topic. It is comprised of 23
peer-reviewed articles, including original research, reviews, opinion pieces, and case reports.
Here, we provide a brief summary of the main findings of the papers included in this
research topic that link inflammatory and immunological mechanisms to the neurobiology of
psychiatric symptomatology.
Herken and Pruess reviewed the neurological and psychiatric presentations of 100 patients
recruited from the Charité Centre for autoimmune encephalitis in Berlin. In this cohort, about
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60% of the individuals presented mainly with psychiatric
symptoms that remained dominant throughout the clinical
course. About one-third of those patients were initially
hospitalized for psychiatric evaluation and treatment. All
patients with anti-NMDR encephalitis exhibited behavioral
disturbances, hallucinations, delusion, short-term memory
deficits, or catatonia. Individuals with other neuronal antibodies
were also frequently admitted with psychosomatic diagnosis. The
authors identified so-called “red and yellow flags” to facilitate
early recognition of patients with autoimmune encephalitis
presenting with neuropsychiatric disturbances, highlighting the
usefulness of incorporating cerebrospinal fluid (CSF) analysis in
the standard diagnostic workup.
Al-Diwani et al. Oxford UK, proposed using a syndrome-
level taxonomy for isolated psychiatric syndromes associated
with neuronal antibodies that can overlap with autoimmune
encephalitis presenting with neuropsychiatric presentations;
synaptic and neuronal autoantibody-associated psychiatric
syndromes or “SNAps.” This pragmatic approach can serve
as a reminder to consider early autoantibody screening for
diagnosing SNAps, potentially permitting early diagnosis and
management of these rare forms of autoimmune encephalitis
that can mimic intractable severe mental disorders. Additional
research is needed to investigate the therapeutic implications of
SNAps and validate their presence as distinct clinical entities.
Ellul et al. provided a thorough review of the clinical
evidence supporting the existence of autoimmune psychosis
as a distinct clinical entity among individuals with new-
onset psychosis, highlighting the diagnostic challenges and
therapeutic implications associated with this entity. The authors
reviewed the clinical and biological features of autoimmune
psychosis, including peripheral biomarkers of autoimmune
dysfunction from dysbiosis to autoantibodies such as NMDAR
antibodies, discussing the interplay between environmental and
genetic factors.
Najjar et al. summarized the clinical and experimental findings
suggestive of the potential contribution of neurovascular
unit dysfunction and blood brain barrier hyperpermeability
to the neurobiology of schizophrenia. These include
neuroinflammation- and oxidative stress-related neurovascular
changes including endothelial dysfunction, leading to increased
cross interactions between brain innate and peripheral adaptic
immunities, thereby perpetuating harmful inflammatory and
immune responses in the CNS. The authors concluded that these
findings provide additional support for the mild encephalitis
(ME) hypothesis of schizophrenia.
Borroto-Escuela et al. reviewed the molecular data supporting
the volume transmission hypothesis with specific relevance
to NMDAR and its pathological allosteric receptor-receptor
interactions that can lead to increased internalization and
decreased NMDAR signaling. Combined with the triplet puzzle
theory it is suggested that mild neuroinflammation is associated
with formation of D2R heteromers, which in turn can
enhance D2R promoter signaling, leading to schizophrenia-
like symptoms.
de Haan et al. reviewed the chronic self-sustaining
immunological and inflammatory changes associated with
neurodegenerative and psychiatric disorders. The findings link
the cascading effects of neuroinflammation and autoimmunity to
disturbances of cholinergic, dopaminergic, glutamatergic,
histaminic, and serotonergic functions, relevant to the
pathophysiology of neuropsychiatric disturbances associated
with neurodegenerative and psychiatric disorders. Thus,
these related neuropsychiatric disorders might benefit from
novel immunotherapies.
De Picker et al. presented a meta-review of recent
quantitative systematic reviews and meta-analyses from
2010 to 2017 investigating the functional relevance of microglial
activation-related immune signaling and brain plasticity to the
pathophysiology of acute psychosis and schizophrenia. This
review included data derived from translocator protein (TSPO)
positron emission tomography, CSF analysis, and post-mortem
studies, coupled with the results of clinical trials pertaining
to the efficacy of various immuno-modulatory agents. They
suggested that microglial activation and its downstream effects
on the immune processes and neuroplasticity can influence the
clinical presentation and the course of schizophrenia. However,
the functional relevance of the cross talks between systemic and
brain inflammation is less clear.
Riedmüller and Müller and Müller and Riedmüller discussed
the potential ethical implications of the ME hypothesis
of schizophrenia that includes shifting our perspective on
schizophrenia from being an incurable psychiatric syndrome
to a chronic but a treatable neurological disease. This will
lead to a newer theoretical conceptualization of schizophrenia
that necessitates interdisciplinary care teams to diagnose and
manage new-onset psychosis and schizophrenia. Moreover, this
reform will have potential repercussions for the pharmaceutical
industry and legal implications surrounding current compulsory
treatment orders. It might also limit social isolation and decreases
the burden and stigma associated with severe mental disorders.
Kocˇovská et al. summarized the role of vitamin D deficiency
as a potential environmental risk factor for three etiologically
distinct disorders; multiple sclerosis, schizophrenia, and autism.
The data suggest that vitamin D deficiency has a much more
robust role in MS, compared with that in schizophrenia and
autism. Further, Endres et al. investigated the prevalence of
vitamin D deficiency in a 1-year cohort of adult inpatients with
schizophreniform (n = 60) and autism spectrum syndromes (n
= 23) at German tertiary care hospital, compared with that
in control group (n = 3,917). Severe deficiencies (<10 ng/ml)
were found more frequently in the schizophreniform (38.3%)
and autism spectrum groups (52.2%), compared to that of
control group (16.3%). These findings justify the need for a
more frequent assessment of serum vitamin D levels in these
disorders, and advocate for additional randomized clinical trials
investigating the effectiveness of vitamin D supplementation in
ameliorating psychiatric and behavioral symptoms.
Endres et al. investigated the prevalence of CSF inflammatory
abnormalities in a seven-year cohort study at the Freiburg
University clinic. In 63 patients with bipolar disorder, CSF
abnormalities, suggestive of mild inflammation, were found in
19% of patients. These include increased albumin quotients
(12.9%), increased immunoglobulin (Ig) G indices (3.2%),
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oligoclonal bands (OCBs) in 1.6%, increased white blood
cell count (1.6%). These findings further support the ME
hypothesis of schizophrenia and autoimmune encephalopathy
masquerading as severe mental disorder.
Vogels et al. verified the previously reported findings of T-
cell deficits and monocyte immune gene activation in a well-
controlled cohort of 97 individuals with largely euthymic bipolar
disorder. Notably, within the decreased T-cell populations,
the counts of T-helper 17 and T-helper 2 were increased
whereas T regulatory cell counts were decreased. Moreover, the
circulating monocytes demonstrated an increased frequency of
anti-inflammatory phenotypes. The authors conclude that T-
cell deficits are likely a trait phenomenon while pro and anti-
inflammatory factors are state dependent in individuals with
bipolar disorder.
Krause et al. showed significantly lower serum kynurenine
level, and higher quinolinic acid/kynurenine (Qui/Kyn) ratio
in a cohort of 32 individuals with major depression, compared
to 20 healthy controls. Higher baseline kynurenine/tryptophan
(KYN/TRP) ratio at baseline was predictive of remission and
lower Qui/Kyn ratio following an add-on treatment with
celecoxib correlated positively with remission. This study
suggests that the measurements of above biomarkers might be
useful in selecting individuals with major depression who are
more likely to respond to anti-inflammatory agents.
Ajdacic-Gross et al. analyzed epidemiological data from the
PsyCoLaus, a large cohort study (n = 3,720) in Switzerland,
to explore the potential association between various early-onset
anxiety disorders and the age at the onset of common viral
childhood illnesses such as chickenpox, measles, and mumps.
The authors found that only social phobia among early anxiety
disorders was associated with delayed-onset viral infections,
suggesting that common viral childhood infections of a delayed
onset may increase the risk of social phobia, speculatively by
infection-induced behavioral changes.
Rahman et al. investigated the developmental effect of
maternal immune activation (MIA), during early and
late gestation, on glutamatergic signaling via NMDAR-
related molecular changes in various brain regions (cortex,
hippocampus, and striatum) in adult rat offspring. The authors
found that MIA can alter NMDAR indices, such as increased
NR2A expression in cortical and hippocampal regions. This
was more prominent in male compared with female offspring,
irrespective of MIA gestational timing. They concluded that
MIA-induced developmental molecular changes including
increased NR2A expression in male offspring might trigger
enduring vulnerability to impaired neuroplasticity and its
consequent behavioral changes.
Sommer et al. investigated the neural effects of the
hydrogen sulfide (H2S, a gaseous molecule), which is
endogenously produced by enzymes utilizing cysteine in
the peripheral and central nervous systems. The authors
also conducted another experiment to analyze the effects
of various antipsychotics on the expression of H2S forming
enzymes in human cell lines. Local sodiumhydrogensulfide
(NaHS) infusion alone into the hippocampus resulted
in a significant increase in the hippocampal glucose and
lactate levels, as well as glutamate release. Pretreatment
with peripheral inflammatory lipopolysaccharide (LPS) was
associated with a further increase in lactate, but without altering
glutamate levels. While NaHS infusion was associated with a
significant increase in hippocampal free radical formation, by
contrast, LPS pretreatment was associated with reduced radical
formation. Additionally, neuroleptics exhibited differential
effects on the H2S forming enzymes, a finding that may be
relevant to understanding the diverse functional effects of
antipsychotic drugs.
Mack et al. reported a case of a young woman presenting
with a 25 years history of dominant psychiatric symptoms,
ranging from depression to typical schizophrenia with fluctuating
psychotic features. The psychiatric symptoms were poorly
responsive to various traditional psychotropic interventions
and required multiple prolonged psychiatric hospitalizations.
Throughout the course of the illness, she had intermittently
exhibited mild skin rashes thought to be related to possible
underlying mixed connective tissue disorder. Indeed, one of her
later relapses was associated with severe generalize exanthema
that resolved rapidly with steroid and azathioprine. KB (the
editor above) suspected that the psychosis is likely related to an
underling systemic immune disorder for which treatment with
azathioprine was maintained, resulting in a complete remission
of the psychiatric syndrome for approximately 16 years. However,
upon azathioprine discontinuation due to pregnancy, the patient
developed a severe relapse of psychosis accompanied by severe
diffuse skin rashes that required a 2 years inpatient psychiatric
care. Treatment with various immunosuppressants, including
belimumab, resulted in a full remission of both psychosis and
skin rashes. The combination of systemic biomarkers for immune
activation and mild CSF inflammatory abnormalities including
the presence of OCBs led to the final diagnosis of atypical Lupus
erythematosus with CNS involvement presenting with dominant
psychiatric manifestations mimicking schizophrenia.
Endres et al. report a case of steroid-responsive chronic
psychosis associated with autoimmune thyroiditis mimicking
antipsychotics-resistant schizophrenia, in the context of several
clinical red flags that collectively pointed to underlying organic
etiopathogenesis. These were intermittent electroencephalogram
(EEG) slowing, mild temporal atrophy, and elevated thyroid
antibodies. This case illustrates the importance of considering
autoimmune psychosis in the differential diagnosis of secondary
(organic) psychosis and to complete the relevant diagnostic
workup to early identify this subgroup of immune-responsive
psychosis. Endres et al. report another case with surprisingly
rapid improvement of chronic schizophrenic symptoms under
newly introduced antiepileptics after having identified respective
suggestive EEG signs.
Ong et al. presented a case of primary Sjögren‘s syndrome
with dominant severe obsessive-compulsive together with
depressive symptoms requiring psychiatric hospitalization. The
diagnosis was eventually made based on the presence of serum
biomarkers of Sjögren‘s syndrome coupled with CSF findings
of mild inflammation. A few months of treatment with various
immunosuppressants together with plasmapheresis resulted in
a complete remission of all neuropsychiatric symptoms. The
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authors suggest that the clinical approach to the management
of psychotropic–resistant obsessive-compulsive disorder should
also include a careful search for biomarkers of inflammation
and autoimmunity.
Greenberg reports a case of severe psychotropic-refractory
pediatric neuropsychiatric syndromemimicking bipolar disorder
thought to be linked to previously unrecognized infection,
likely Bartonellosis. The presentation and the clinical course
did not meet “pediatric autoimmune neuropsychiatric disorders
associated with streptococcal infections” (PANDAS) criteria. The
patient exhibited a clinically meaningful response to antibiotics
targeting Bartonella infection. This case illustrates that prior
clinically unrecognized infections can serve as immunological
triggers of secondary psychiatric illnesses.
Klein provided a thorough review of the clinical and
experimental evidence supporting the “viral hypothesis of
schizophrenia.” The author suggests that HSV-1 infection of
specific limbic brain regions such as hippocampal dentate
gyrus among other factors is potentially mechanistically linked
to psychosis in a subset of individuals with schizophrenia.
The mechanisms potentially linking viral infections to the
neurobiology of schizophrenia were highlighted. The author
suggests that silencing the viral elements such asHSV-1, via either
administering antiviral treatment or suppressing environmental
factors that can influence viral expression such as stress can
thereby potentially be curative in a subgroup of individuals
with schizophrenia.
In summary, the data from these reports strengthen
the evidence linking immune dysfunction, autoimmunity,
and neuroinflammation to various primary psychiatric
illnesses including schizophrenia and affective spectrum
disorders. Alternatively, they also show that brain autoimmune
disorders such as autoimmune encephalitis and autoimmune
encephalopathy can also present with diverse neuropsychiatric
syndromes masquerading as severe mental disorders such
as primary psychotic disorders unresponsive to traditional
psychotropic and behavioral interventions. Thus, it is critical
to obtain a detailed history, perform a thorough examination,
recognize clinical features (red flags) suggestive of organic
causes, and complete a relevant diagnostic workup to include
screening for relevant neuronal antibodies in serum and CSF
to exclude other organic causes, in order not to overlook
immunological causes of new-onset secondary (organic)
neuropsychiatric syndromes. Collectively, the above data also
support the ME hypothesis of schizophrenia and severe mental
illness (1, 2) and the concept of autoimmune psychosis (3)
mechanistically linking the neurobiology of a subset of psychosis
to underlying inflammatory and immunological changes in the
brain. Additional research studies investigating the prevalence
of autoimmune psychosis among individuals with new-onset
psychosis are needed. Further, development of an expert
consensus on the evidence-based clinical practice guidelines
addressing the diagnostic challenges and therapeutic dilemmas
of new-onset psychosis of suspected immune origin is warranted.
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